Cargando…
Prediction of Microvascular Invasion of Hepatocellular Carcinoma Based on Contrast-Enhanced MR and 3D Convolutional Neural Networks
BACKGROUND AND PURPOSE: It is extremely important to predict the microvascular invasion (MVI) of hepatocellular carcinoma (HCC) before surgery, which is a key predictor of recurrence and helps determine the treatment strategy before liver resection or liver transplantation. In this study, we demonst...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040801/ https://www.ncbi.nlm.nih.gov/pubmed/33854959 http://dx.doi.org/10.3389/fonc.2021.588010 |
_version_ | 1783677847301259264 |
---|---|
author | Zhou, Wu Jian, Wanwei Cen, Xiaoping Zhang, Lijuan Guo, Hui Liu, Zaiyi Liang, Changhong Wang, Guangyi |
author_facet | Zhou, Wu Jian, Wanwei Cen, Xiaoping Zhang, Lijuan Guo, Hui Liu, Zaiyi Liang, Changhong Wang, Guangyi |
author_sort | Zhou, Wu |
collection | PubMed |
description | BACKGROUND AND PURPOSE: It is extremely important to predict the microvascular invasion (MVI) of hepatocellular carcinoma (HCC) before surgery, which is a key predictor of recurrence and helps determine the treatment strategy before liver resection or liver transplantation. In this study, we demonstrate that a deep learning approach based on contrast-enhanced MR and 3D convolutional neural networks (CNN) can be applied to better predict MVI in HCC patients. MATERIALS AND METHODS: This retrospective study included 114 consecutive patients who were surgically resected from October 2012 to October 2018 with 117 histologically confirmed HCC. MR sequences including 3.0T/LAVA (liver acquisition with volume acceleration) and 3.0T/e-THRIVE (enhanced T1 high resolution isotropic volume excitation) were used in image acquisition of each patient. First, numerous 3D patches were separately extracted from the region of each lesion for data augmentation. Then, 3D CNN was utilized to extract the discriminant deep features of HCC from contrast-enhanced MR separately. Furthermore, loss function for deep supervision was designed to integrate deep features from multiple phases of contrast-enhanced MR. The dataset was divided into two parts, in which 77 HCCs were used as the training set, while the remaining 40 HCCs were used for independent testing. Receiver operating characteristic curve (ROC) analysis was adopted to assess the performance of MVI prediction. The output probability of the model was assessed by the independent student’s t-test or Mann-Whitney U test. RESULTS: The mean AUC values of MVI prediction of HCC were 0.793 (p=0.001) in the pre-contrast phase, 0.855 (p=0.000) in arterial phase, and 0.817 (p=0.000) in the portal vein phase. Simple concatenation of deep features using 3D CNN derived from all the three phases improved the performance with the AUC value of 0.906 (p=0.000). By comparison, the proposed deep learning model with deep supervision loss function produced the best results with the AUC value of 0.926 (p=0.000). CONCLUSION: A deep learning framework based on 3D CNN and deeply supervised net with contrast-enhanced MR could be effective for MVI prediction. |
format | Online Article Text |
id | pubmed-8040801 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80408012021-04-13 Prediction of Microvascular Invasion of Hepatocellular Carcinoma Based on Contrast-Enhanced MR and 3D Convolutional Neural Networks Zhou, Wu Jian, Wanwei Cen, Xiaoping Zhang, Lijuan Guo, Hui Liu, Zaiyi Liang, Changhong Wang, Guangyi Front Oncol Oncology BACKGROUND AND PURPOSE: It is extremely important to predict the microvascular invasion (MVI) of hepatocellular carcinoma (HCC) before surgery, which is a key predictor of recurrence and helps determine the treatment strategy before liver resection or liver transplantation. In this study, we demonstrate that a deep learning approach based on contrast-enhanced MR and 3D convolutional neural networks (CNN) can be applied to better predict MVI in HCC patients. MATERIALS AND METHODS: This retrospective study included 114 consecutive patients who were surgically resected from October 2012 to October 2018 with 117 histologically confirmed HCC. MR sequences including 3.0T/LAVA (liver acquisition with volume acceleration) and 3.0T/e-THRIVE (enhanced T1 high resolution isotropic volume excitation) were used in image acquisition of each patient. First, numerous 3D patches were separately extracted from the region of each lesion for data augmentation. Then, 3D CNN was utilized to extract the discriminant deep features of HCC from contrast-enhanced MR separately. Furthermore, loss function for deep supervision was designed to integrate deep features from multiple phases of contrast-enhanced MR. The dataset was divided into two parts, in which 77 HCCs were used as the training set, while the remaining 40 HCCs were used for independent testing. Receiver operating characteristic curve (ROC) analysis was adopted to assess the performance of MVI prediction. The output probability of the model was assessed by the independent student’s t-test or Mann-Whitney U test. RESULTS: The mean AUC values of MVI prediction of HCC were 0.793 (p=0.001) in the pre-contrast phase, 0.855 (p=0.000) in arterial phase, and 0.817 (p=0.000) in the portal vein phase. Simple concatenation of deep features using 3D CNN derived from all the three phases improved the performance with the AUC value of 0.906 (p=0.000). By comparison, the proposed deep learning model with deep supervision loss function produced the best results with the AUC value of 0.926 (p=0.000). CONCLUSION: A deep learning framework based on 3D CNN and deeply supervised net with contrast-enhanced MR could be effective for MVI prediction. Frontiers Media S.A. 2021-03-04 /pmc/articles/PMC8040801/ /pubmed/33854959 http://dx.doi.org/10.3389/fonc.2021.588010 Text en Copyright © 2021 Zhou, Jian, Cen, Zhang, Guo, Liu, Liang and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zhou, Wu Jian, Wanwei Cen, Xiaoping Zhang, Lijuan Guo, Hui Liu, Zaiyi Liang, Changhong Wang, Guangyi Prediction of Microvascular Invasion of Hepatocellular Carcinoma Based on Contrast-Enhanced MR and 3D Convolutional Neural Networks |
title | Prediction of Microvascular Invasion of Hepatocellular Carcinoma Based on Contrast-Enhanced MR and 3D Convolutional Neural Networks |
title_full | Prediction of Microvascular Invasion of Hepatocellular Carcinoma Based on Contrast-Enhanced MR and 3D Convolutional Neural Networks |
title_fullStr | Prediction of Microvascular Invasion of Hepatocellular Carcinoma Based on Contrast-Enhanced MR and 3D Convolutional Neural Networks |
title_full_unstemmed | Prediction of Microvascular Invasion of Hepatocellular Carcinoma Based on Contrast-Enhanced MR and 3D Convolutional Neural Networks |
title_short | Prediction of Microvascular Invasion of Hepatocellular Carcinoma Based on Contrast-Enhanced MR and 3D Convolutional Neural Networks |
title_sort | prediction of microvascular invasion of hepatocellular carcinoma based on contrast-enhanced mr and 3d convolutional neural networks |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040801/ https://www.ncbi.nlm.nih.gov/pubmed/33854959 http://dx.doi.org/10.3389/fonc.2021.588010 |
work_keys_str_mv | AT zhouwu predictionofmicrovascularinvasionofhepatocellularcarcinomabasedoncontrastenhancedmrand3dconvolutionalneuralnetworks AT jianwanwei predictionofmicrovascularinvasionofhepatocellularcarcinomabasedoncontrastenhancedmrand3dconvolutionalneuralnetworks AT cenxiaoping predictionofmicrovascularinvasionofhepatocellularcarcinomabasedoncontrastenhancedmrand3dconvolutionalneuralnetworks AT zhanglijuan predictionofmicrovascularinvasionofhepatocellularcarcinomabasedoncontrastenhancedmrand3dconvolutionalneuralnetworks AT guohui predictionofmicrovascularinvasionofhepatocellularcarcinomabasedoncontrastenhancedmrand3dconvolutionalneuralnetworks AT liuzaiyi predictionofmicrovascularinvasionofhepatocellularcarcinomabasedoncontrastenhancedmrand3dconvolutionalneuralnetworks AT liangchanghong predictionofmicrovascularinvasionofhepatocellularcarcinomabasedoncontrastenhancedmrand3dconvolutionalneuralnetworks AT wangguangyi predictionofmicrovascularinvasionofhepatocellularcarcinomabasedoncontrastenhancedmrand3dconvolutionalneuralnetworks |